Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0021218067
Thu, 12.05.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRDistribution agreement signed with Tovani Benzaquen Ingredients to jointly develop the Brazilian business
Minimum revenues of CHF 1.5 million expected from the partnership
Reinach, May 12, 2022 – Evolva (SIX:EVE), a pioneer in the field of natural molecules and in [ … ]
Thu, 05.05.2022
Evolva Holding SA
Evolva Holding SA
/ Key word(s): AGMEGM
Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2022
05.05.2022 / 18:05
Press Release (PDF)
PRESS RELEASE
Reinach, May 05, 2022 – Shareholders of Evolva (SIX:EVE), a pioneer in the field of natural molecules and industrial biotech, approved all proposals [ … ]
Wed, 20.04.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRFirst commercial batch successfully produced according to specifications of the customer, after prior successful completion of demo and engineering batches
Related revenues of more than 20% of last year's total revenues triggered, which are expected to accrue in 20 [ … ]
Thu, 07.04.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRReinach, April 7, 2022 - Evolva (SIX:EVE) today announced that it has postponed its AGM 2022, which was originally scheduled for April 12, 2022 to May 5, 2022 due to technical reasons. The agenda items and proposals of the Board of Directors remain unchanged.
The n [ … ]
Tue, 22.03.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRElection of Andreas Pfluger, a senior leader with broad international experience especially in consumer goods industries, as Richard Ridinger is not standing for re-election, but will continue to support Evolva in an advisory role
Election of Andreas Weigelt as Boa [ … ]
Thu, 10.03.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRReinach, March 10, 2022 - Evolva (SIX:EVE) today reports full-year 2021 total revenue of CHF 9.9 million. Product-related revenues grew 40% from CHF 6.6 million to CHF 9.1 million, with all business segments contributing to the growth. During 2021, the company signi [ … ]
Mon, 28.02.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRReinach, February 28, 2022 - Evolva (SIX:EVE), a pioneer in the field of natural molecules and industrial biotech, has transformed in recent years from a R&D stage company to a commercial company with an innovative specialty-fermentation platform and a product-b [ … ]
Tue, 08.02.2022
Evolva Holding SA
Ad Hoc Announcement (PDF)
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRReinach, February 8, 2022 - Evolva (SIX:EVE), a pioneer in the field of natural molecules and industrial biotech, has transformed in recent years from an R&D stage company with services-based revenues to a commercial company with an innovative technology at its [ … ]
Mon, 27.12.2021
Evolva Holding SA
Reinach, December 27, 2021 - Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of products based on nature, today signed an agreement with Nice & Green, a Swiss investment firm, to secure additional financing lines until the end of 2023.
The financing lines can be drawn by Evolva in quarterl [ … ]
Tue, 30.11.2021
Evolva Holding SA
Reinach, November 30, 2021 - Evolva (SIX:EVE), the Swiss biotech company focused on the research, development and commercialization of ingredients based on nature, announced today that it has entered into a Purchase and Subscription Agreement with VERAISON SICAV Engagement Fund ('VERAISON') to purchase 63'751'116 shares in a private placement, r [ … ]